Three things investors will be looking for in Biogen's Q3 earnings
October 24, 2022 at 05:45 AM EDT
The drugmaker will again face analysts on Tuesday amid cautious hope for its neurodegenerative disease drugs and an ongoing CEO search. Here's what to watch for.
